PGFC
NVO

Peapack-Gladstone Financial Corp’s Novo Nordisk NVO Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.77M Sell
78,574
-2,869
-4% -$123K 0.04% 276
2026
Q1 		$2.99M Buy
81,443
+8,352
+11% +$396K 0.04% 298
2025
Q4 		$3.72M Sell
73,091
-25,083
-26% -$1.28M 0.05% 271
2025
Q3 		$5.45M Buy
98,174
+22,525
+30% +$1.32M 0.07% 226
2025
Q2 		$5.22M Buy
75,649
+46,535
+160% +$3.17M 0.07% 225
2025
Q1 		$2.02M Buy
29,114
+1
+0% +$83 0.03% 330
2024
Q4 		$2.5M Buy
29,113
+957
+3% +$103K 0.04% 296
2024
Q3 		$3.35M Buy
28,156
+4,122
+17% +$550K 0.05% 275
2024
Q2 		$3.43M Buy
24,034
+776
+3% +$103K 0.05% 258
2024
Q1 		$2.99M Buy
23,258
+3,603
+18% +$429K 0.05% 276
2023
Q4 		$2.03M Buy
19,655
+904
+5% +$89.4K 0.03% 318
2023
Q3 		$1.71M Buy
18,751
+4,489
+31% +$395K 0.03% 316
2023
Q2 		$1.15M Buy
14,262
+4,048
+40% +$331K 0.02% 373
2023
Q1 		$813K Buy
10,214
+3,360
+49% +$238K 0.02% 408
2022
Q4 		$464K Buy
6,854
+176
+3% +$10.3K 0.01% 472
2022
Q3 		$333K Sell
6,678
-200
-3% -$10.7K 0.01% 524
2022
Q2 		$383K Hold
6,878
– – 0.01% 477
2022
Q1 		$382K Hold
6,878
– – 0.01% 516
2021
Q4 		$385K Hold
6,878
– – 0.01% 512
2021
Q3 		$330K Hold
6,878
– – 0.01% 529
2021
Q2 		$288K Hold
6,878
– – 0.01% 525
2021
Q1 		$232K Hold
6,878
– – 0.01% 537
2020
Q4 		$240K Hold
6,878
– – 0.01% 380
2020
Q3 		$239K Hold
6,878
– – 0.01% 335
2020
Q2 		$225K Sell
6,878
-1,462
-18% -$46.7K 0.01% 348
2020
Q1 		$251K Buy
8,340
+614
+8% +$18.3K 0.01% 319
2019
Q4 		$224K Buy
+7,726
New +$214K 0.01% 334

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Peapack-Gladstone Financial Corp's NVO Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp reduced its Novo Nordisk (NVO) stake by 3.5% in Q2 2026, selling an estimated $123K and leaving 78,574 shares worth $3.77M. The position accounts for 0.04% of the portfolio, ranked #276.

Peapack-Gladstone Financial Corp first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.45M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 78,574 shares of Novo Nordisk worth $3.77M as of Q2 2026.
  • Peapack-Gladstone Financial Corp sold 2,869 Novo Nordisk shares in Q2 2026, an estimated $123K.
  • Novo Nordisk made up 0.04% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #276 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • Peapack-Gladstone Financial Corp's Novo Nordisk position peaked at $5.45M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.